Stocks  /  NASDAQ  /  LB Pharmaceuticals Inc

LB Pharmaceuticals Inc

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   LBRX – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

LB Pharmaceuticals Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for drug testing.

“LB-102 displays superior dopamine receptor occupancy compared to amisulpride in mouse and human PET studies (P.0830 )” Read the full document

Company Description

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Company Website: https://lbpharma.us

Contact:  IR@lbpharma.us
Scroll to Top